Using ex vivo explants from estrogen receptor-positive, estrogen receptor mutant, and triple-negative breast cancer patients, we demonstrate that CB blocks breast cancer growth and metastasis without affecting normal breast tissue. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.